ScholarIQanswers from OpenAlex

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.

PaperCitations, authors & open-access status

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. have?

ScholarIQcitation count

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. has 247 citations in the OpenAlex counts ScholarIQ stores.

When was Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. published?

ScholarIQyear

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. has 1994 year in the ScholarIQ index.

What is the open-access status of Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.?

ScholarIQoa status

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. has closed oa status in the ScholarIQ index.

What is the DOI of Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.?

ScholarIQdoi

The DOI for Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. is on the source record.

What is the PMID of Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.?

ScholarIQpmid

The PMID for Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. is on the source record.

What is the OpenAlex record for Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.?

ScholarIQopenalex

The OpenAlex for Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial